The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Unintended Hepatic Adverse Events Associated with Cancer Chemotherapy
Abstract
Chemotherapy is meant to be toxic, but it is particularly aimed at the tumor cells. Collateral damage may occur to normal cells and tissues, especially if they are fairly rapidly regenerating, as is the case for bone marrow cells, intestinal epithelial cells, and liver cells after hepatic injury. The liver has a great capacity to resist injury, overcome it, and to regenerate, even after quite massive injury (resection of 50%—65%, for example). This capacity may make it susceptible to chemotherapeutic toxicity, and a struggle between injury and adaptation, leading to recovery and tolerance or to failure and death. If the chemotherapy is aimed just at delaying progression of the cancer for a few weeks or months, it may not be worth the risk of irreversible liver injury developing in that time. Close clinical observation and sound clinical judgment are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when patients are educated to self‐monitor and stop drugs when symptoms occur, ALF and death can be averted.189”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Research works printed but not linked: 28
- 10.1111/j.1525-1497.2004.30091.x · DOI · Paper page
- 2003, Preclinica, 2, 27
- 10.1517/17425250902927386 · DOI
- 10.5414/CPP47153 · doi:10.5414/cpp47153
- 10.1136/gut.12.11.922 · doi:10.1136/gut.12.11.922
- 10.1016/S1470-2045(09)70064-6 · DOI · Paper page
- 10.2174/157488408784293697 · DOI
- 10.1002/hep.510280640 · DOI
- Davidson, C. S., Leevy, C. M., and Chamberlayne, E. C. (eds.) (1979). Guidelines for Detection of Hepatotoxicity due to Drugs and Chemicals. [Fogarty Conference, 1978] NIH Publication No. 79-313. US Government Printing Office, Washington, DC, p. 109.
- 2005, Oncology, 19, 1057
- 10.1016/S1470-2045(08)70279-1 · DOI
- 10.1016/S1470-2045(08)70307-3 · DOI
- 10.1053/j.seminoncol.2005.11.002 · DOI · Paper page
- 10.2165/00002018-200932010-00005 · DOI · Paper page
- 10.1016/S0002-9343(02)01529-2 · DOI · Paper page
- 10.7326/0003-4819-137-1-200207020-00012 · DOI
- 10.1172/JCI103055 · DOI · Paper page
- 10.1016/S0889-8553(21)00236-3 · doi:10.1016/s0889-8553(21)00236-3
- 1978, Am Rev Resp Dis, 117, 991
- 10.1016/0360-3016(94)00418-K · DOI · Paper page
- 10.1126/science.130.3366.9 · DOI · Paper page
- 2007, Common Toxicity Criteria for Adverse Events (CTCAE), version 3.0
- 10.1001/jama.281.11.1014 · DOI · Paper page
- 10.1158/1078-0432.CCR-06-3067 · DOI · Paper page
- 1999, Drugs and the Liver: What They Do To Each Other
- 10.7326/0003-4819-138-2-200301210-00021 · doi:10.7326/0003-4819-138-2-200301210-00021
- 2008, Hepatology, 48, 506A, 10.1002/hep.22642 · doi:10.1002/hep.22642
- 10.1002/pds.1211 · DOI · Paper page
Cited by
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Metadata
- Authors
- Senior, J. R.
- Affiliations
- Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, john.senior@fda.hhs.gov
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2009-10-26
- Volume
- 38
- Issue
- 1
- Pages
- 142-147
- ISSN
- 0192-6233
- 1533-1601
- Cited by
- 26
- References
- 1
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unintended Hepatic Adverse Events Associated with Cancer Chemotherapy. https://app.cochat.ai/papers/10.1177/0192623309351719
- The paper
- Senior, J. R. (2010). Unintended Hepatic Adverse Events Associated with Cancer Chemotherapy. Toxicologic Pathology. https://doi.org/10.1177/0192623309351719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.